Protocol and Clinical Program Excellence Director

London
3 weeks ago
Applications closed

Related Jobs

View all jobs

Director, Clinical Operations Lead

Principal Biostatistician

Director, Medical Writing Resourcing Group Lead

Medical Devices Clinical Safety

Associate Director, Clinical Trial Disclosure & Transparency

Associate Director, Clinical Trial Disclosure & Transparency

Protocol & Clinical Program Excellence Director
Contract Length - 12 -18 months
Rate - £570/day via Umbrella only
Hybrid from London office

Job Description Summary
The Protocol & Clinical Program Excellence Director will provide strategic,
scientific planning and operational execution support to the Head Protocol &
Clinical Program Excellence to deliver on the CD program excellence goals
aligned with the overall CD strategy and vision.
The role will support the scientific and operational activities of CD Central
Integrated Scientific Review Committee (C-ISRC) and work closely with Head
Protocol & Clinical Program Excellence, C-ISRC Leads, CD(M)Ds and trial
teams, as well as cross functional partner functions as needed.
This role is based in the UK / London and in a hybrid working approach
Job Description
Provides scientific and operational support to the Central Integrated Scientific Review
Committee (C-ISRC), supporting, as requested, the Head Protocol & Clinical Program
Excellence with the review of Clinical Development Plans (CDPs) and Key clinical
documents (Study protocols, DMC charters, etc), to maintain high levels of quality and
consistency across the therapeutic areas.

*Develops harmonized processes, tools and resources to enable a seamless C-ISRC
process
*Supports and acts as delegate to the Head Protocol & Clinical Program Excellence in
activities like interactions with external stakeholders (e.g., regulatory authorities, key
opinion leaders, data monitoring committees, advisory boards etc.) and internal NVS
stakeholders as needed.
*Supports enhancement and simplification of the clinical development approach
(CDP, clinical trial designs, protocol and its review) to improve speed and outcome success
of clinical programs.
*Engages the CD(M)Ds and the broader CD community around clinical learnings across
therapeutic areas. Supports the CD talent step-up strategy. Supports strategic directions
for professional CD capability building.
*Supports the Head Protocol & Clinical Program Excellence to build cross-function
collaborations and initiatives leading to a step-wised transition to the futuristic digital clinical
trial era.

Education and minimum experience

MD or advanced degree in life sciences/healthcare (or clinically relevant degree) is
required. PharmD, or PhD strongly preferred

  • More than 5 years of involvement in clinical research or drug development in an academic
    or industry environment spanning clinical activities in Phases I through IV.
    More than 3 years of contribution to and accomplishment in all aspects of conducting
    clinical trials (e.g., planning, executing, reporting and publishing) in a global/matrix
    environment in pharmaceutical industry
    *Excellent interpersonal, negotiation, conflict resolution verbal and written communication
    skills

  • Strong skills at influencing without formal authority
  • Fluent oral and written English

    Guidant, Carbon60, Lorien & SRG - The Impellam Group Portfolio are acting as an Employment Business in relation to this vacancy

Subscribe to Future Tech Insights for the latest jobs & insights, direct to your inbox.

By subscribing, you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Neurodiversity in Biotech Careers: Turning Different Thinking into a Superpower

Biotechnology is all about solving complex problems that affect real lives – from new medicines & vaccines to sustainable materials, diagnostics & gene therapies. To tackle those challenges, the sector needs people who think differently. That is exactly where neurodivergent talent comes in. If you have ADHD, autism, dyslexia or another form of neurodivergence, you might have been told that your brain is “too much”, “too distracted” or “too literal” for a lab or scientific career. In reality, many of the traits that come with ADHD, autism & dyslexia are perfectly suited to biotech work – from spotting subtle patterns in experimental data to creative thinking around new solutions. This guide is written for biotechnology job seekers in the UK. We will explore: What neurodiversity means in a biotech context How ADHD, autism & dyslexia strengths map onto specific biotech roles Practical workplace adjustments you can ask for under UK law How to talk about your neurodivergence in applications & interviews By the end, you will have a clearer idea of where you might thrive in biotech – & how to set up your working environment so your differences become genuine superpowers.

Biotechnology Hiring Trends 2026: What to Watch Out For (For Job Seekers & Recruiters)

As we move into 2026, the biotechnology jobs market in the UK is going through rapid change. Funding cycles are tighter, some organisations are restructuring or consolidating, & yet demand for specialist biotech skills remains strong – particularly in areas like cell & gene therapy, bioprocessing, mRNA platforms, bioinformatics & regulatory affairs. New therapies are coming through the pipeline, advanced manufacturing facilities are scaling up, & digital tools are transforming lab & clinical workflows. At the same time, some roles are being automated, outsourcing patterns are shifting, & hiring standards are rising. Whether you are a biotech job seeker planning your next move, or a recruiter trying to build teams in a complex market, understanding the key biotechnology hiring trends for 2026 will help you stay ahead.

Biotechnology Recruitment Trends 2025 (UK): What Job Seekers Must Know About Today’s Hiring Process

Summary: UK biotechnology hiring has shifted from title-led CV screens to capability-driven assessments that emphasise validated lab results, documentation, GxP/QA/RA awareness, data literacy, digital biology tools & measurable impact from bench to bedside. This guide explains what’s changed, what to expect in interviews & how to prepare—especially for wet-lab scientists, bioprocess/CMC engineers, QC/QA specialists, RA/clinical professionals, bioinformatics/data scientists & platform engineers. Who this is for: Biologists, biochemists, biotechnologists, cell & gene therapy scientists, upstream/downstream processing engineers, QA/QC analysts, validation engineers, regulatory affairs specialists, clinical trial professionals, bioinformaticians, data scientists & biotech product/operations managers targeting roles in the UK.